NO983474D0 - Expression of Group B Neisseria meningitidis outer membrane protein (MB3) from yeast and vaccines - Google Patents
Expression of Group B Neisseria meningitidis outer membrane protein (MB3) from yeast and vaccinesInfo
- Publication number
- NO983474D0 NO983474D0 NO983474A NO983474A NO983474D0 NO 983474 D0 NO983474 D0 NO 983474D0 NO 983474 A NO983474 A NO 983474A NO 983474 A NO983474 A NO 983474A NO 983474 D0 NO983474 D0 NO 983474D0
- Authority
- NO
- Norway
- Prior art keywords
- vaccines
- yeast
- expression
- group
- membrane protein
- Prior art date
Links
- 108010052285 Membrane Proteins Proteins 0.000 title 1
- 102000018697 Membrane Proteins Human genes 0.000 title 1
- 241000588650 Neisseria meningitidis Species 0.000 title 1
- 101710116435 Outer membrane protein Proteins 0.000 title 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1097296P | 1996-02-01 | 1996-02-01 | |
US2044096P | 1996-06-13 | 1996-06-13 | |
PCT/US1997/001687 WO1997028273A1 (en) | 1996-02-01 | 1997-01-31 | Expression of group b neisseria meningitidis outer membrane (mb3) protein from yeast and vaccines |
Publications (2)
Publication Number | Publication Date |
---|---|
NO983474D0 true NO983474D0 (en) | 1998-07-28 |
NO983474L NO983474L (en) | 1998-09-30 |
Family
ID=26681820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO983474A NO983474L (en) | 1996-02-01 | 1998-07-28 | Expression of Group B Neisseria meningitidis outer membrane (MB3) protein from yeast and vaccines |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0877816A1 (en) |
JP (1) | JP2001508758A (en) |
KR (1) | KR19990082265A (en) |
AU (1) | AU2115897A (en) |
HU (1) | HUP9901039A2 (en) |
IL (1) | IL125420A0 (en) |
NO (1) | NO983474L (en) |
PL (1) | PL328096A1 (en) |
WO (1) | WO1997028273A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6451317B1 (en) | 1997-07-17 | 2002-09-17 | Baxter International Inc. | Immunogenic conjugates comprising a Group B meningococcal porin and an H influenzae polysaccharide |
CN101293920B (en) | 1998-05-01 | 2012-07-18 | 诺华疫苗和诊断公司 | Neisseria meningitidis antigens and compositions |
DE69941406D1 (en) * | 1998-07-06 | 2009-10-22 | Tosoh Corp | IL-6 receptor IL-6-coupled fusion protein |
JP4524816B2 (en) * | 1998-07-06 | 2010-08-18 | 東ソー株式会社 | IL-6 receptor / IL-6 direct fusion protein |
GB9818004D0 (en) * | 1998-08-18 | 1998-10-14 | Smithkline Beecham Biolog | Novel compounds |
JP2003518363A (en) | 1999-04-30 | 2003-06-10 | カイロン エセ.ピー.アー. | Conserved Neisseria antigen |
ID30407A (en) | 1999-05-13 | 2001-11-29 | American Cyanamid Co | COMBINATION FORM FOR ADDITION MATERIALS |
EP2270174A1 (en) * | 1999-05-19 | 2011-01-05 | Novartis Vaccines and Diagnostics S.r.l. | Combination neisserial compositions |
EP1069133A1 (en) * | 1999-07-13 | 2001-01-17 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Neisseria meningitidis compounds and anti-infection applications thereof |
GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
JP4840956B2 (en) * | 1999-11-29 | 2011-12-21 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | 85kDa Neisseria antigen |
ES2588917T3 (en) | 2000-01-17 | 2016-11-07 | Glaxosmithkline Biologicals Sa | VME supplement supplemented against meningococcus |
CN100339482C (en) | 2000-02-28 | 2007-09-26 | 启龙股份公司 | Hybrid expression of neisserial proteins |
GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
SI2351579T1 (en) | 2002-10-11 | 2017-05-31 | Glaxosmithkline Biologicals Sa | Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages |
CA2514328C (en) | 2003-01-30 | 2020-01-14 | Chiron Srl | Injectable vaccines against multiple meningococcal serogroups |
JP2006262846A (en) * | 2005-03-25 | 2006-10-05 | Niigata Bio Research Park Kk | Method for the synthesis and purification of 2-deoxy-siro-inosose by yeast and the resulting 2-deoxy-siro-inosose |
KR100919704B1 (en) * | 2007-09-12 | 2009-10-06 | 한국생명공학연구원 | High-efficiency secretion of recombinant proteins in yeast |
JP2011116658A (en) * | 2008-03-13 | 2011-06-16 | Chemo-Sero-Therapeutic Research Inst | Manufacturing method of medicine for swine atrophic rhinitis |
US9974848B2 (en) | 2013-11-14 | 2018-05-22 | Duke University | Tetanus toxoid and CCL3 improve DC vaccines |
CN106146679B (en) * | 2015-04-23 | 2019-02-01 | 中国医学科学院医学生物学研究所 | A kind of method of purification of bacterial capsular polysaccharide |
ES2908463T3 (en) | 2015-05-11 | 2022-04-29 | Impossible Foods Inc | Expression constructs and methods of genetic engineering of methylotrophic yeasts |
US11441099B2 (en) * | 2015-12-30 | 2022-09-13 | Dsm Ip Assets B.V. | Partial enzymatic hydrolysis of triacylglycerols |
CA3137100A1 (en) * | 2019-04-17 | 2020-10-22 | Impossible Foods Inc. | Materials and methods for protein production |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4356170A (en) * | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
NZ239643A (en) * | 1990-09-17 | 1996-05-28 | North American Vaccine Inc | Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group. |
US5268273A (en) * | 1990-12-14 | 1993-12-07 | Phillips Petroleum Company | Pichia pastoris acid phosphatase gene, gene regions, signal sequence and expression vectors comprising same |
US5439808A (en) * | 1993-07-23 | 1995-08-08 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
-
1997
- 1997-01-31 EP EP97906470A patent/EP0877816A1/en not_active Ceased
- 1997-01-31 JP JP52788197A patent/JP2001508758A/en active Pending
- 1997-01-31 HU HU9901039A patent/HUP9901039A2/en unknown
- 1997-01-31 WO PCT/US1997/001687 patent/WO1997028273A1/en not_active Application Discontinuation
- 1997-01-31 PL PL97328096A patent/PL328096A1/en unknown
- 1997-01-31 IL IL12542097A patent/IL125420A0/en unknown
- 1997-01-31 KR KR1019980705994A patent/KR19990082265A/en not_active Application Discontinuation
- 1997-01-31 AU AU21158/97A patent/AU2115897A/en not_active Abandoned
-
1998
- 1998-07-28 NO NO983474A patent/NO983474L/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2001508758A (en) | 2001-07-03 |
HUP9901039A2 (en) | 1999-07-28 |
AU2115897A (en) | 1997-08-22 |
KR19990082265A (en) | 1999-11-25 |
PL328096A1 (en) | 1999-01-04 |
WO1997028273A1 (en) | 1997-08-07 |
IL125420A0 (en) | 1999-03-12 |
NO983474L (en) | 1998-09-30 |
EP0877816A1 (en) | 1998-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO983474D0 (en) | Expression of Group B Neisseria meningitidis outer membrane protein (MB3) from yeast and vaccines | |
NO960256D0 (en) | Expression, purification and refolding of Neisseria Meningitidis outer membrane group B protein proteins | |
IL99401A (en) | Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations | |
IS4879A (en) | Preparations of dispersible macromolecules and methods for their preparation and use | |
NO993676L (en) | Process for the preparation and purification of an N-alkylated aspartame derivative | |
DK1185666T3 (en) | Hyaluronidase from Hirudinaria manillensis, isolation, purification and recombinant method of preparation | |
IS4345A (en) | Substituted N- (indole-2-carbonyl) -b-alaninamide, their use and pharmaceutical preparations | |
DK0935441T3 (en) | Method and apparatus for mapping cortical connections | |
NO972781D0 (en) | Aerosol formulations of peptides and proteins | |
DE69623116D1 (en) | GAS PERMEABLE MEMBRANE | |
CA2310888A1 (en) | Monoclonal human natural antibodies | |
FI953025L (en) | Impermeable and breathable membrane | |
NO972214L (en) | Process for Purification and Isolation of 2'-Deoxy-2 ', 2'-Difluoronucleosides | |
NO971650L (en) | Renibacterium salmoninarum vaccine and method of preparation thereof | |
DK0711501T3 (en) | Method and apparatus for separating at least one piece of visceral tissue from at least one organ connected therein | |
NO974727D0 (en) | Immunogenic and immunostimulatory oligosaccharide compositions and methods for their preparation | |
DK0845943T3 (en) | New peptides derived from human heat shock protein 60 for the treatment of diabetes, compositions, methods and kits | |
NO982712D0 (en) | Methods and intermediates for the preparation of 1-benzyl-4 - ((5,6-dimethoxy-1-indanone) -2-yl) methylpiperidine | |
DK0784986T3 (en) | Artificial hair for implantation and method of preparation thereof | |
NO995034D0 (en) | Dental implant system and method of manufacture thereof | |
NO951750L (en) | Purified "nontypable" Haemophilus influenzae P5 protein as a vaccine for "nontypable" Haemophilus influenzae strain | |
DE69624128D1 (en) | INHIBITANT AND NON-INHIBITING ANTI-BINDING POLYPEPTIDES AGAINST HUMAN P450 ENZYMS | |
NO911025D0 (en) | PROCEDURE FOR INSULATION AND EXPRESSION OF HUMAN CILIAR NEURONOTROPIC FACTOR BY RECOMBINANT DNA TECHNOLOGY. | |
AU5735299A (en) | Basb024 outer membrane protein of neisseria meningitidis | |
AU1087199A (en) | Human vesicle membrane protein-like proteins |